- Auteur:
- Eduardo Anitua
- María de la Fuente
- Francisco Muruzabal
- Jesús Merayo-Lloves
Development and optimization of a personalized fibrin membrane derived from the plasma rich in growth factors technology
Exp Eye Res. 2021 Feb:203:108402. To develop and characterize a new type of plasma rich in growth factors (PRGF) membrane for patients in which immune system is involved in the disease etiology
- Auteur:
- Eduardo Anitua
- Ronald M Sanchez-Avila
- Edmar E Uribe-Badillo
- Javier Fernández-Vega Sanz
- Francisco Muruzabal
- Nancy Jurado
- Belén Alfonso-Bartolozzi
- Jose F Alfonso
- Begoña Baamonde
- Jesus Merayo-Lloves
Plasma rich in growth factors versus Mitomycin C in photorefractive keratectomy
Medicine (Baltimore). 2021 Jan 22;100(3):e24139. To evaluate the efficacy and safety of plasma rich in growth factors (PRGF) in photorefractive keratectomy (PRK) versus Mitomycin C (MMC).This is a comparative, longitudinal and retrospective case-control study (MMC vs PRGF), in patients with a spherical correction from -0.25 to -8.00 D and cylinder correction from -0.25 to -3.00
- Auteur:
- Eduardo Anitua
- Sabino Padilla
- Mikel Sánchez
- Victor Vaquerizo
- Gerard A Malanga
- Nicolás Fiz
- Juan Azofra
- Christopher J Rogers
- Gonzalo Samitier
- Steven Sampson
- Roberto Seijas
- Ricardo Elorriaga
- Jack Taunton
- Frank Boehm
- Roberto Prado
- Ramón Cugat
Platelet-Rich Plasma Applications for Achilles Tendon Repair: A Bridge between Biology and Surgery
Int J Mol Sci. 2021 Jan 15;22(2):824. Achilles tendon ruptures are very common tendon ruptures and their incidence is increasing in modern society, resulting in work incapacity and months off sport, which generate a need for accelerated and successful therapeutic repair strategy. Platelet-rich plasma (PRP) is emerging as adjuvant human blood-derived constructs to assist Achilles tendon rupture treatment
- Auteur:
- Eduardo Anitua
- María de la Fuente
- Francisco Muruzábal
- Jesús Merayo-Lloves
Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops
Cornea. 2021 Jan;40(1):107-112. To analyze whether plasma rich in growth factors (PRGFs) eye drops preserve their activity and biological properties after storage for 9 and 12 months at -20°C, and at 4°C, and at room temperature (RT) for 3 and 7 days in comparison to fresh samples (t0)
- Auteur:
- Eduardo Anitua
- Mohammad H. Alkhraisat
- Sofía Fernández de Retana
Platelet rich plasma in oral and maxillofacial surgery from the perspective of composition
Platelets. 2021 Feb 17;32(2):174-182. The application of platelet-rich plasma (PRP) in oral and maxillofacial surgery has been thoroughly studied in the last two decades. Currently, different types of PRP are applied in the clinical practice, being the presence or absence of leukocytes one of the classification criteria. However, there is poor evidence assessing the influence of the PRP composition in their efficacy.
- Auteur:
- Eduardo Anitua
- Gorka Orive
- Mar Zalduendo
- María Troya
- Sabino Padilla
Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties
PLoS One. 2015 Mar 30;10(3):e0121713. One of the main differences among platelet-rich plasma (PRP) products is the inclusion of leukocytes that may affect the biological efficacy of these autologous preparations. The purpose of this study was to evaluate whether the addition of leukocytes modified the morphological, biomechanical and biological properties of PRP under normal and inflammatory conditions.